Smith Group Asset Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-155,670
| Closed | -$1.63M | – | 479 |
|
|
2015
Q4 | $1.63M | Sell |
155,670
-21,340
| -12% | -$223K | 0.05% | 154 |
|
|
2015
Q3 | $1.18M | Buy |
177,010
+170,570
| +2,649% | +$1.14M | 0.05% | 159 |
|
|
2015
Q2 | $43K | Buy |
6,440
+550
| +9% | +$3.67K | ﹤0.01% | 283 |
|
|
2015
Q1 | $40K | Buy |
5,890
+770
| +15% | +$5.23K | ﹤0.01% | 337 |
|
|
2014
Q4 | $41K | Hold |
5,120
| – | – | ﹤0.01% | 318 |
|
|
2014
Q3 | $18K | Hold |
5,120
| – | – | ﹤0.01% | 308 |
|
|
2014
Q2 | $24K | Sell |
5,120
-205,338
| -98% | -$963K | ﹤0.01% | 301 |
|
|
2014
Q1 | $2M | Sell |
210,458
-2,211
| -1% | -$21K | 0.08% | 160 |
|
|
2013
Q4 | $1.38M | Buy |
212,669
+71,547
| +51% | +$465K | 0.05% | 169 |
|
|
2013
Q3 | $1.07M | Buy |
+141,122
| New | +$1.07M | 0.04% | 177 |
|